Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 2, 2001 - Issue 6
Submit an article Journal homepage
33
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

Nateglinide: a new rapid-acting insulinotropic agent

Sudhesh Kumar Undergraduate Centre, Birmingham Heartlands Hospital, Bordsley Green East, Birmingham, B9 5SS, UK. [email protected]
&
Wasim Hanif Undergraduate Centre, Birmingham Heartlands Hospital, Bordsley Green East, Birmingham, B9 5SS, UK. [email protected]
Pages 1027-1031 | Published online: 24 Feb 2005

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Meiling Qi, Peng Wang, Yujing Sun & Ying Li. (2003) Determination of the L‐Enantiomer of Nateglinide in a Bulk Drug Substance by Chiral Reversed‐Phase Liquid Chromatography. Journal of Liquid Chromatography & Related Technologies 26:11, pages 1839-1845.
Read now

Articles from other publishers (3)

Koji Nishi, Ayana Yano, Kenji Tsukigawa, Victor TG Chuang, Masaki Otagiri & Keishi Yamasaki. (2022) Effect of Fatty Acids and Uremic Toxins on the Binding of Nateglinide, an Insulin Secretagogue, to Site II on Human Serum Albumin. Biological and Pharmaceutical Bulletin 45:6, pages 803-805.
Crossref
D. Nagasamy Venkatesh, S.N. Meyyanathan, R. Shanmugam, A. Zielinska, J.R. Campos, J.D. Ferreira & E.B. Souto. (2020) Development, in vitro release and in vivo bioavailability of sustained release nateglinide tablets. Journal of Drug Delivery Science and Technology 55, pages 101355.
Crossref
Zhi-Xu He, Zhi-Wei Zhou, Yinxue Yang, Tianxin Yang, Si-Yuan Pan, Jia-Xuan Qiu & Shu-Feng Zhou. (2015) Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus. Clinical and Experimental Pharmacology and Physiology 42:2, pages 125-138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.